- Home
- STRO vs XTNT Comparison
STRO vs XTNT Comparison
Compare STRO & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- XTNT
- Stock Information
- Founded
- STRO 2003
- XTNT N/A
- Country
- STRO United States
- XTNT United States
- Employees
- STRO N/A
- XTNT N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STRO Health Care
- XTNT Health Care
- Exchange
- STRO Nasdaq
- XTNT Nasdaq
- Market Cap
- STRO 69.1M
- XTNT 82.1M
- IPO Year
- STRO 2018
- XTNT N/A
- Fundamental
- Price
- STRO $0.97
- XTNT $0.62
- Analyst Decision
- STRO Hold
- XTNT
- Analyst Count
- STRO 7
- XTNT 0
- Target Price
- STRO $1.97
- XTNT N/A
- AVG Volume (30 Days)
- STRO 553.4K
- XTNT 91.3K
- Earning Date
- STRO 08-07-2025
- XTNT 08-12-2025
- Dividend Yield
- STRO N/A
- XTNT N/A
- EPS Growth
- STRO N/A
- XTNT N/A
- EPS
- STRO N/A
- XTNT N/A
- Revenue
- STRO $104,473,000.00
- XTNT $127,766,000.00
- Revenue This Year
- STRO $65.42
- XTNT $13.03
- Revenue Next Year
- STRO N/A
- XTNT N/A
- P/E Ratio
- STRO N/A
- XTNT N/A
- Revenue Growth
- STRO N/A
- XTNT 15.16
- 52 Week Low
- STRO $0.52
- XTNT $0.33
- 52 Week High
- STRO $4.80
- XTNT $0.78
- Technical
- Relative Strength Index (RSI)
- STRO 58.41
- XTNT 49.51
- Support Level
- STRO $0.90
- XTNT $0.59
- Resistance Level
- STRO $1.18
- XTNT $0.65
- Average True Range (ATR)
- STRO 0.09
- XTNT 0.04
- MACD
- STRO 0.01
- XTNT -0.00
- Stochastic Oscillator
- STRO 43.43
- XTNT 47.67
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.